Robert A Newman Selected Research

eupalmerin acetate

1/2007

Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Newman Research Topics

Disease

72	Neoplasms (Cancer) 01/2022 - 05/2002
18	Carcinogenesis 07/2010 - 05/2002
11	Inflammation (Inflammations) 01/2015 - 09/2002
9	Pancreatic Neoplasms (Pancreatic Cancer) 06/2016 - 12/2007
7	Neoplasm Metastasis (Metastasis) 06/2016 - 09/2004
7	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 05/2002
7	Breast Neoplasms (Breast Cancer) 09/2009 - 05/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 11/2002
6	Lung Neoplasms (Lung Cancer) 07/2014 - 09/2002
5	Infections 01/2022 - 01/2019
5	Adenoma (Adenomas) 06/2009 - 12/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2008 - 09/2004
4	Melanoma (Melanoma, Malignant) 01/2011 - 01/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2020
3	COVID-19 06/2021 - 01/2020
3	Adenocarcinoma 10/2020 - 09/2004
3	Stroke (Strokes) 01/2020 - 11/2011
3	Ischemic Stroke 12/2016 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 04/2014 - 07/2008
3	Colonic Neoplasms (Colon Cancer) 04/2014 - 09/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 11/2007
3	Carcinoma (Carcinomatosis) 07/2008 - 08/2006
3	Ovarian Neoplasms (Ovarian Cancer) 10/2007 - 03/2003
2	Nausea 10/2020 - 06/2003
2	Vomiting 10/2020 - 06/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2016
2	Wounds and Injuries (Trauma) 01/2016 - 12/2012
2	Hyperplasia 11/2008 - 07/2008
2	Squamous Cell Carcinoma of Head and Neck 11/2008 - 09/2004
2	Leukemia 11/2008 - 08/2002
2	Mouth Neoplasms (Oral Cancer) 07/2008 - 12/2006
2	Fatigue 04/2004 - 06/2003
2	Ascites 09/2003 - 03/2003
1	Severe Acute Respiratory Syndrome 06/2021

Drug/Important Bio-Agent (IBA)

15	oleandrinIBA 01/2022 - 01/2006
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
14	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2009 - 11/2002
13	Cardiac GlycosidesIBA 01/2022 - 01/2006
12	Proteins (Proteins, Gene)FDA Link 12/2016 - 05/2002
11	Dinoprostone (PGE2)FDA Link 07/2014 - 12/2002
11	EnzymesIBA 07/2014 - 08/2002
11	Arachidonic Acid (Vitamin F)IBA 10/2012 - 09/2002
10	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2012 - 09/2002
10	ProstaglandinsIBA 06/2009 - 09/2002
9	PBI-05204IBA 01/2022 - 11/2011
8	LipidsIBA 08/2009 - 03/2003
7	Celecoxib (Celebrex)FDA Link 02/2010 - 09/2004
7	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2009 - 11/2002
6	Protein Isoforms (Isoforms)IBA 04/2014 - 01/2008
6	EicosanoidsIBA 05/2008 - 09/2004
5	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2016
5	Leukotriene B4IBA 07/2010 - 09/2006
5	Lipoxygenase (Lipoxygenase-1)IBA 07/2010 - 09/2002
5	Prostaglandins EIBA 06/2009 - 09/2002
4	Adenosine Triphosphatases (ATPase)IBA 04/2014 - 01/2008
4	Messenger RNA (mRNA)IBA 10/2012 - 09/2003
4	ZyflamendIBA 01/2011 - 01/2007
4	CurcuminIBA 11/2009 - 10/2005
4	NF-kappa B (NF-kB)IBA 09/2009 - 10/2005
4	15-hydroxyprostaglandin dehydrogenaseIBA 06/2009 - 08/2006
4	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2009 - 09/2006
4	anthraceneIBA 11/2008 - 09/2006
4	Hydroxyeicosatetraenoic Acids (HETE)IBA 10/2007 - 02/2005
3	Fish OilsIBA 07/2014 - 06/2004
3	AcidsIBA 07/2010 - 05/2002
3	AzoxymethaneIBA 06/2009 - 08/2006
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2009 - 06/2003
3	PPAR gammaIBA 01/2009 - 03/2005
3	Biological ProductsIBA 07/2008 - 05/2002
3	Cisplatin (Platino)FDA LinkGeneric 09/2004 - 05/2002
2	VaccinesIBA 06/2021 - 07/2020
2	CytokinesIBA 01/2015 - 07/2008
2	Eicosapentaenoic AcidIBA 07/2014 - 06/2004
2	prostaglandin E3 (PGE3)IBA 07/2014 - 05/2008
2	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 10/2012 - 10/2007
2	LipoxygenasesIBA 10/2012 - 09/2004
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2011 - 11/2009
2	13-hydroxy-9,11-octadecadienoic acidIBA 07/2010 - 10/2007
2	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 04/2009 - 06/2006
2	AntioxidantsIBA 09/2008 - 08/2007
2	ErbB Receptors (EGF Receptor)IBA 07/2008 - 12/2004
2	Phosphotransferases (Kinase)IBA 07/2008 - 01/2007
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2008 - 05/2008
2	5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA 10/2007 - 01/2005
2	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 10/2007 - 01/2005
2	LeukotrienesIBA 10/2007 - 12/2006
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2007 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2006 - 09/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2005 - 11/2002
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 05/2005 - 07/2003
2	aseanostatin P5IBA 01/2005 - 06/2003
2	Caspase 3 (Caspase-3)IBA 01/2005 - 06/2003
2	SolutionsIBA 09/2004 - 09/2003
2	Phosphates (Orthophosphate)IBA 09/2003 - 03/2003
2	lysophosphatidic acidIBA 09/2003 - 03/2003
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 10/2020

Therapy/Procedure

11	Therapeutics 07/2020 - 08/2002
9	Drug Therapy (Chemotherapy) 10/2020 - 11/2002
6	Chemoprevention 02/2010 - 09/2006
3	Radiotherapy 01/2022 - 01/2020